Beta Bionics Inc Sustainability Reports
Beta Bionics, Inc. is a medical technology company that designs, develops, and commercializes automated insulin delivery systems. Its flagship product, the iLet Bionic Pancreas, utilizes advanced adaptive closed-loop algorithms to automate insulin dosing for people with diabetes.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00JNGG9R1
3 reports from 2019 to 2021
